Using murine cancer models, we demonstrate that the CXCL1 signalling through its receptors is rate-limiting for the obesity-associated ASC recruitment to tumours and their stimulatory effects on tumour vascularization and growth. This evidence concerns the gene CXCL1 and obesity due to melanocortin 4 receptor deficiency.